Comparing healthy controls, Rosenbaum et al. found significantly altered gene expression within these pathways, which is why the authors concluded that GPA, sarcoidosis and NSOI patient might also profit from blockade of IGF-1R signaling pathways. This evidence concerns the gene IGF1R and sarcoidosis.